View drug registration information details.
| Items | Registration information |
|---|
| ID | 1641 |
|---|
| No | 1641 |
|---|
| Brand Name | CABOZAN 20 MG |
|---|
| Ingredients | CABOZANTINIB 20 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | 90 TABLETS/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR TREATMENT OF PATIENTS WITH PROGRESSIVE, METASTATIC MEDULLARY THYROID CANCER, RENAL CELL CARCINOMA AND HEPATOCELLULAR CARCINOMA. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | RED CAPSULE |
|---|
| Note | |
|---|
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 L 0957/23 |
|---|
| FDD Registration Date | 31-MAR-2025 |
|---|
| Expiry Date | 30-MAR-2030 |
|---|
Back to drug list
|
